Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder

Objective: A recent double-blind randomized placebo-controlled study demonstrated 3-month efficacy and safety of a novel pediatric-appropriate prolonged-release melatonin (PedPRM) for insomnia in children and adolescents with autism spectrum disorder (ASD) and neurogenetic disorders (NGD) with/witho...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Child Adolesc Psychopharmacol
Главные авторы: Maras, Athanasios, Schroder, Carmen M., Malow, Beth A., Findling, Robert L., Breddy, John, Nir, Tali, Shahmoon, Shiri, Zisapel, Nava, Gringras, Paul
Формат: Artigo
Язык:Inglês
Опубликовано: Mary Ann Liebert, Inc., publishers 2018
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6306655/
https://ncbi.nlm.nih.gov/pubmed/30132686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2018.0020
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы